

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.67242694 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.67242694 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.28211583 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.28211583 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.91364152 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29195914 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.28513728 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.18094532 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.18094532 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.18094532 |
| 11 | cysteine metabolic process (GO:0006534) | 5.16919888 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.06554775 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.04898937 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.01430138 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.81240562 |
| 16 | urea cycle (GO:0000050) | 4.76094249 |
| 17 | urea metabolic process (GO:0019627) | 4.76094249 |
| 18 | hemoglobin metabolic process (GO:0020027) | 4.70054498 |
| 19 | protein carboxylation (GO:0018214) | 4.68464274 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68464274 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.66751577 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.61265109 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.57152502 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45885467 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.41720884 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.41261547 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.37557545 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.37162138 |
| 29 | glutamate metabolic process (GO:0006536) | 4.33487409 |
| 30 | bile acid metabolic process (GO:0008206) | 4.32402361 |
| 31 | lysine catabolic process (GO:0006554) | 4.25550685 |
| 32 | lysine metabolic process (GO:0006553) | 4.25550685 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.24647513 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.16302839 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.13700558 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 4.13322806 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.13322806 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.11997253 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.10999596 |
| 40 | regulation of complement activation (GO:0030449) | 4.10170162 |
| 41 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09633490 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.06366353 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.05032558 |
| 44 | plasma lipoprotein particle assembly (GO:0034377) | 4.05028136 |
| 45 | coenzyme catabolic process (GO:0009109) | 4.00858159 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 3.97740151 |
| 47 | phospholipid efflux (GO:0033700) | 3.97384326 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 3.96740024 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.92204667 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.92204667 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92204667 |
| 52 | cellular glucuronidation (GO:0052695) | 3.91026107 |
| 53 | drug catabolic process (GO:0042737) | 3.90783469 |
| 54 | acylglycerol homeostasis (GO:0055090) | 3.88984865 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.88984865 |
| 56 | cholesterol efflux (GO:0033344) | 3.88410207 |
| 57 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.86872881 |
| 58 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84092055 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.83489492 |
| 60 | response to methylmercury (GO:0051597) | 3.81644920 |
| 61 | hepatocyte apoptotic process (GO:0097284) | 3.81036878 |
| 62 | ethanol oxidation (GO:0006069) | 3.80311194 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 3.80202689 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.76937216 |
| 65 | ovulation from ovarian follicle (GO:0001542) | 3.76543595 |
| 66 | regulation of cholesterol homeostasis (GO:2000188) | 3.74675918 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.74500329 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.69918641 |
| 69 | bile acid and bile salt transport (GO:0015721) | 3.68571232 |
| 70 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.58785342 |
| 71 | amine catabolic process (GO:0009310) | 3.58736677 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 3.58736677 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 3.56189352 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.53027947 |
| 75 | regulation of RNA export from nucleus (GO:0046831) | 3.49323844 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.48654446 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.48623763 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.46461439 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.46461439 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.45132636 |
| 81 | response to nitrosative stress (GO:0051409) | 3.44227003 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.41950346 |
| 83 | positive regulation of receptor recycling (GO:0001921) | 3.40951781 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.40215611 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.40154028 |
| 86 | aspartate family amino acid catabolic process (GO:0009068) | 3.38896959 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.38745509 |
| 88 | plasma lipoprotein particle organization (GO:0071827) | 3.38563918 |
| 89 | cofactor catabolic process (GO:0051187) | 3.37172768 |
| 90 | drug transmembrane transport (GO:0006855) | 3.36749470 |
| 91 | definitive hemopoiesis (GO:0060216) | 3.35118084 |
| 92 | negative regulation of complement activation (GO:0045916) | 3.34795405 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.34187656 |
| 94 | iron ion import (GO:0097286) | 3.33743972 |
| 95 | epoxygenase P450 pathway (GO:0019373) | 3.31988219 |
| 96 | fibrinolysis (GO:0042730) | 3.31535376 |
| 97 | flavonoid metabolic process (GO:0009812) | 3.31534715 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.31402454 |
| 99 | erythrocyte development (GO:0048821) | 3.29396356 |
| 100 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.29196102 |
| 101 | arginine metabolic process (GO:0006525) | 3.29026455 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.28387457 |
| 103 | heme transport (GO:0015886) | 3.27175470 |
| 104 | protein-lipid complex subunit organization (GO:0071825) | 3.26541075 |
| 105 | sterol homeostasis (GO:0055092) | 3.23758723 |
| 106 | glycine metabolic process (GO:0006544) | 3.22249903 |
| 107 | ketone body metabolic process (GO:1902224) | 3.21878914 |
| 108 | histone H3-K9 demethylation (GO:0033169) | 3.20914933 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.19544652 |
| 110 | organic acid catabolic process (GO:0016054) | 3.19544652 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.15430702 |
| 112 | N-terminal protein amino acid acetylation (GO:0006474) | 3.15358511 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.15231867 |
| 114 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.12049209 |
| 115 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.10122837 |
| 116 | fibroblast migration (GO:0010761) | 3.08488454 |
| 117 | opsonization (GO:0008228) | 3.08259609 |
| 118 | histone H3-K36 demethylation (GO:0070544) | 3.07899870 |
| 119 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.06002739 |
| 120 | oxygen transport (GO:0015671) | 3.04054451 |
| 121 | protein K11-linked deubiquitination (GO:0035871) | 3.03874054 |
| 122 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.03785613 |
| 123 | protein K48-linked deubiquitination (GO:0071108) | 2.97938878 |
| 124 | detection of molecule of bacterial origin (GO:0032490) | 2.95497238 |
| 125 | pericardium development (GO:0060039) | 2.95334704 |
| 126 | import into cell (GO:0098657) | 2.95001299 |
| 127 | macroautophagy (GO:0016236) | 2.92111959 |
| 128 | cellular response to ethanol (GO:0071361) | 2.88151313 |
| 129 | myeloid cell development (GO:0061515) | 2.86949243 |
| 130 | negative regulation of anoikis (GO:2000811) | 2.85516378 |
| 131 | interkinetic nuclear migration (GO:0022027) | 2.84195995 |
| 132 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.83321726 |
| 133 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.83197318 |
| 134 | positive regulation of fibroblast migration (GO:0010763) | 2.82836603 |
| 135 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81476460 |
| 136 | histone mRNA catabolic process (GO:0071044) | 2.79624906 |
| 137 | nerve growth factor signaling pathway (GO:0038180) | 2.77486223 |
| 138 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.75340689 |
| 139 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.74724567 |
| 140 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.74724567 |
| 141 | regulation of platelet aggregation (GO:0090330) | 2.74699886 |
| 142 | COPII vesicle coating (GO:0048208) | 2.74419946 |
| 143 | regulation of pigment cell differentiation (GO:0050932) | 2.74358757 |
| 144 | growth hormone receptor signaling pathway (GO:0060396) | 2.74065098 |
| 145 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.72862233 |
| 146 | erythrocyte maturation (GO:0043249) | 2.72294585 |
| 147 | gas transport (GO:0015669) | 2.71046808 |
| 148 | negative regulation of DNA repair (GO:0045738) | 2.70002492 |
| 149 | regulation of response to osmotic stress (GO:0047484) | 2.69568006 |
| 150 | regulation of protein polyubiquitination (GO:1902914) | 2.68153492 |
| 151 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.68037372 |
| 152 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.65888254 |
| 153 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.63457074 |
| 154 | positive regulation of muscle hypertrophy (GO:0014742) | 2.63457074 |
| 155 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.62691775 |
| 156 | glycoprotein catabolic process (GO:0006516) | 2.61127188 |
| 157 | nuclear pore complex assembly (GO:0051292) | 2.58929849 |
| 158 | protein targeting to Golgi (GO:0000042) | 2.56037961 |
| 159 | negative regulation of humoral immune response (GO:0002921) | 2.55255046 |
| 160 | cellular response to epinephrine stimulus (GO:0071872) | 2.54884592 |
| 161 | establishment of protein localization to Golgi (GO:0072600) | 2.50650582 |
| 162 | embryonic process involved in female pregnancy (GO:0060136) | 2.48587331 |
| 163 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.48536357 |
| 164 | extracellular fibril organization (GO:0043206) | 2.47121583 |
| 165 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.47085466 |
| 166 | corticosteroid receptor signaling pathway (GO:0031958) | 2.46776241 |
| 167 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.46617798 |
| 168 | cellular response to growth hormone stimulus (GO:0071378) | 2.45580435 |
| 169 | nuclear pore organization (GO:0006999) | 2.45149223 |
| 170 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.43100052 |
| 171 | positive regulation of macroautophagy (GO:0016239) | 2.42232886 |
| 172 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.41427509 |
| 173 | negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736) | 2.38934584 |
| 174 | regulation of muscle hypertrophy (GO:0014743) | 2.38613266 |
| 175 | protein targeting to vacuole (GO:0006623) | 2.38439731 |
| 176 | protein targeting to lysosome (GO:0006622) | 2.38439731 |
| 177 | establishment of protein localization to vacuole (GO:0072666) | 2.38439731 |
| 178 | cortical actin cytoskeleton organization (GO:0030866) | 2.38111957 |
| 179 | nucleus localization (GO:0051647) | 2.36192033 |
| 180 | histone lysine demethylation (GO:0070076) | 2.35376760 |
| 181 | blood vessel maturation (GO:0001955) | 2.34669340 |
| 182 | cellular response to gamma radiation (GO:0071480) | 2.34044555 |
| 183 | cellular response to virus (GO:0098586) | 2.33601373 |
| 184 | response to lead ion (GO:0010288) | 2.33395987 |
| 185 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.33312878 |
| 186 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.32512031 |
| 187 | hypotonic response (GO:0006971) | 2.32132908 |
| 188 | peptidyl-lysine trimethylation (GO:0018023) | 2.30954140 |
| 189 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.30597105 |
| 190 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.29638232 |
| 191 | protein K63-linked deubiquitination (GO:0070536) | 2.29324724 |
| 192 | regulation of receptor recycling (GO:0001919) | 2.28525748 |
| 193 | fibril organization (GO:0097435) | 2.28478114 |
| 194 | negative regulation of fatty acid transport (GO:2000192) | 2.28232819 |
| 195 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27487199 |
| 196 | phospholipid translocation (GO:0045332) | 2.27427750 |
| 197 | lipid translocation (GO:0034204) | 2.27427750 |
| 198 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.27400529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.40802456 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10968385 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.17633331 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.05379094 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.45045062 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.83973339 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.78058836 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.36834524 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26479543 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91630626 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.87718291 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.74772378 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.21164162 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.15144063 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09983327 |
| 16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.04569720 |
| 17 | TP53_16413492_ChIP-PET_HCT116_Human | 2.04446570 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01778005 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.86522155 |
| 20 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80721170 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77742122 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71849626 |
| 23 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.69011842 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64568187 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.59176947 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58569448 |
| 27 | GATA1_19941826_ChIP-Seq_K562_Human | 1.58188962 |
| 28 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.57828146 |
| 29 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.56561136 |
| 30 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52940912 |
| 31 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.52760062 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51987586 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50113439 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49467650 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49131451 |
| 36 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.48530368 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48442952 |
| 38 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43481318 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42851370 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42537911 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41557383 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41033533 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36813495 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36528453 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33415513 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33045538 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29908231 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29732224 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28422614 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27574096 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26967643 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25995314 |
| 53 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.24745529 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22108264 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22072036 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20839513 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20583257 |
| 58 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.20358700 |
| 59 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19195208 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18908068 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18872029 |
| 62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18541468 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18251771 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15893633 |
| 65 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.15689327 |
| 66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15553683 |
| 67 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.14905753 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13017663 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12723786 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12055873 |
| 71 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09882996 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09859132 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08358464 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06891856 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06747036 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06513379 |
| 77 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.06455381 |
| 78 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05660051 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05195306 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04455653 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04233772 |
| 82 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04096729 |
| 83 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03584338 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03239343 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03151154 |
| 86 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03125624 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02476862 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01977279 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01734760 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01648128 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01560842 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01191704 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01146487 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01028796 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00892412 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00892412 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00349886 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98989643 |
| 99 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98787674 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94577008 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93449836 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93009309 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92169411 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92104371 |
| 105 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87718903 |
| 106 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87605656 |
| 107 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86674216 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85008849 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85000516 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84862717 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84642054 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84049169 |
| 113 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83510681 |
| 114 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83510681 |
| 115 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83422442 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82367627 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80723692 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80509888 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79274640 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78658668 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.78218442 |
| 122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76948613 |
| 123 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76089092 |
| 124 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75524949 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73899605 |
| 126 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73851245 |
| 127 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73767793 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73735324 |
| 129 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73119539 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72624593 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72278145 |
| 132 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71545175 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70460598 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.69472627 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69465484 |
| 136 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68914746 |
| 137 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.68202274 |
| 138 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.67708463 |
| 139 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66189414 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65819910 |
| 141 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65557266 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.65499263 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.65370536 |
| 144 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.65086622 |
| 145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64797770 |
| 146 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.64660975 |
| 147 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.64257504 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.64091675 |
| 149 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64082338 |
| 150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62548948 |
| 151 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.62303600 |
| 152 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.62279701 |
| 153 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.62279701 |
| 154 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60670303 |
| 155 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.60316755 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59846470 |
| 157 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.58288646 |
| 158 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.58283841 |
| 159 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.58229559 |
| 160 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.58109786 |
| 161 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.58067131 |
| 162 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.57791059 |
| 163 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.57431107 |
| 164 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.57361771 |
| 165 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.57073443 |
| 166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.57061601 |
| 167 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.56274007 |
| 168 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.56112898 |
| 169 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.55210607 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54939496 |
| 171 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.54744195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82926171 |
| 2 | MP0005360_urolithiasis | 7.44647546 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.78596516 |
| 4 | MP0005365_abnormal_bile_salt | 5.48315042 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00368307 |
| 6 | MP0000569_abnormal_digit_pigmentation | 4.99390811 |
| 7 | MP0003252_abnormal_bile_duct | 3.99716969 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.97789955 |
| 9 | MP0008057_abnormal_DNA_replication | 3.55594166 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.40042066 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.30109205 |
| 12 | MP0005083_abnormal_biliary_tract | 3.14235826 |
| 13 | MP0008260_abnormal_autophagy | 3.00927215 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.66615560 |
| 15 | MP0005332_abnormal_amino_acid | 2.62685236 |
| 16 | MP0009840_abnormal_foam_cell | 2.57172214 |
| 17 | MP0006054_spinal_hemorrhage | 2.47923130 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.42340494 |
| 19 | MP0005409_darkened_coat_color | 2.42077776 |
| 20 | MP0003195_calcinosis | 2.34856403 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.33664925 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.32916865 |
| 23 | MP0005275_abnormal_skin_tensile | 2.32894410 |
| 24 | MP0003091_abnormal_cell_migration | 2.17989847 |
| 25 | MP0001958_emphysema | 2.15653817 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.08415877 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.07804150 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 2.06785026 |
| 29 | MP0003566_abnormal_cell_adhesion | 2.04910548 |
| 30 | MP0000609_abnormal_liver_physiology | 2.00102748 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.92210551 |
| 32 | MP0004272_abnormal_basement_membrane | 1.84483096 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.82080897 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.77363530 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.75728828 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.70196593 |
| 37 | MP0005503_abnormal_tendon_morphology | 1.66692010 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.65235493 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.63477445 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.62677720 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.61990145 |
| 42 | MP0004883_abnormal_blood_vessel | 1.60291265 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59437005 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.59106131 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.57081517 |
| 46 | MP0003828_pulmonary_edema | 1.56681144 |
| 47 | MP0002009_preneoplasia | 1.56638173 |
| 48 | MP0003868_abnormal_feces_composition | 1.53630241 |
| 49 | MP0003279_aneurysm | 1.53553147 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.51354395 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.51354395 |
| 52 | MP0003690_abnormal_glial_cell | 1.50810394 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.43249252 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.41690229 |
| 55 | MP0005164_abnormal_response_to | 1.39520406 |
| 56 | MP0001915_intracranial_hemorrhage | 1.35913150 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.35614803 |
| 58 | MP0004484_altered_response_of | 1.28638027 |
| 59 | MP0000604_amyloidosis | 1.24990042 |
| 60 | MP0005621_abnormal_cell_physiology | 1.22288160 |
| 61 | MP0010307_abnormal_tumor_latency | 1.21580917 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.19831640 |
| 63 | MP0005187_abnormal_penis_morphology | 1.19732108 |
| 64 | MP0003011_delayed_dark_adaptation | 1.19633489 |
| 65 | MP0005623_abnormal_meninges_morphology | 1.13358734 |
| 66 | MP0003329_amyloid_beta_deposits | 1.11976180 |
| 67 | MP0009764_decreased_sensitivity_to | 1.09286001 |
| 68 | MP0003941_abnormal_skin_development | 1.06310899 |
| 69 | MP0004147_increased_porphyrin_level | 1.03690698 |
| 70 | MP0005388_respiratory_system_phenotype | 1.02866891 |
| 71 | MP0002133_abnormal_respiratory_system | 1.02866891 |
| 72 | MP0000013_abnormal_adipose_tissue | 1.02601668 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 1.02448451 |
| 74 | MP0005451_abnormal_body_composition | 1.00916765 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.00742963 |
| 76 | MP0001764_abnormal_homeostasis | 1.00542011 |
| 77 | MP0003186_abnormal_redox_activity | 0.99451144 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.97943933 |
| 79 | MP0000733_abnormal_muscle_development | 0.97332494 |
| 80 | MP0002108_abnormal_muscle_morphology | 0.96749123 |
| 81 | MP0000598_abnormal_liver_morphology | 0.96192664 |
| 82 | MP0000749_muscle_degeneration | 0.95236205 |
| 83 | MP0009763_increased_sensitivity_to | 0.95221554 |
| 84 | MP0004885_abnormal_endolymph | 0.94880424 |
| 85 | MP0005647_abnormal_sex_gland | 0.94841932 |
| 86 | MP0004043_abnormal_pH_regulation | 0.94542748 |
| 87 | MP0002006_tumorigenesis | 0.94274940 |
| 88 | MP0008874_decreased_physiological_sensi | 0.94066935 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.93818864 |
| 90 | MP0004130_abnormal_muscle_cell | 0.93211878 |
| 91 | MP0002971_abnormal_brown_adipose | 0.92765431 |
| 92 | MP0001851_eye_inflammation | 0.91913712 |
| 93 | MP0005535_abnormal_body_temperature | 0.88625206 |
| 94 | MP0002128_abnormal_blood_circulation | 0.88141016 |
| 95 | MP0002060_abnormal_skin_morphology | 0.87423503 |
| 96 | MP0005384_cellular_phenotype | 0.87328779 |
| 97 | MP0008004_abnormal_stomach_pH | 0.86304518 |
| 98 | MP0002822_catalepsy | 0.86300464 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.85258318 |
| 100 | MP0000920_abnormal_myelination | 0.84922303 |
| 101 | MP0004036_abnormal_muscle_relaxation | 0.84401389 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.81944081 |
| 103 | MP0001784_abnormal_fluid_regulation | 0.79851913 |
| 104 | MP0000427_abnormal_hair_cycle | 0.79111585 |
| 105 | MP0003075_altered_response_to | 0.78937349 |
| 106 | MP0005334_abnormal_fat_pad | 0.78878332 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.77625710 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 0.77604304 |
| 109 | MP0000371_diluted_coat_color | 0.76920735 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.75821071 |
| 111 | MP0009703_decreased_birth_body | 0.75731072 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.75321947 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.74461743 |
| 114 | MP0002925_abnormal_cardiovascular_devel | 0.74305661 |
| 115 | MP0005023_abnormal_wound_healing | 0.73480294 |
| 116 | MP0002269_muscular_atrophy | 0.71950758 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.71082726 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.70854613 |
| 119 | MP0000428_abnormal_craniofacial_morphol | 0.70563482 |
| 120 | MP0002254_reproductive_system_inflammat | 0.70440150 |
| 121 | MP0001614_abnormal_blood_vessel | 0.69225198 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.69158159 |
| 123 | MP0008469_abnormal_protein_level | 0.69140137 |
| 124 | MP0003115_abnormal_respiratory_system | 0.68639646 |
| 125 | MP0000266_abnormal_heart_morphology | 0.67657617 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.66470812 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.66058494 |
| 128 | MP0001661_extended_life_span | 0.65668684 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.65135911 |
| 130 | MP0002088_abnormal_embryonic_growth/wei | 0.64708261 |
| 131 | MP0002928_abnormal_bile_duct | 0.64043610 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.63446473 |
| 133 | MP0009697_abnormal_copulation | 0.63013972 |
| 134 | MP0000858_altered_metastatic_potential | 0.62780413 |
| 135 | MP0004134_abnormal_chest_morphology | 0.62648128 |
| 136 | MP0001756_abnormal_urination | 0.62582818 |
| 137 | MP0003633_abnormal_nervous_system | 0.62287453 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.62252608 |
| 139 | MP0002168_other_aberrant_phenotype | 0.61543126 |
| 140 | MP0003303_peritoneal_inflammation | 0.61195841 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.60124544 |
| 142 | MP0002090_abnormal_vision | 0.59681077 |
| 143 | MP0004142_abnormal_muscle_tone | 0.59437863 |
| 144 | MP0005464_abnormal_platelet_physiology | 0.58242552 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.56118583 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.55769025 |
| 147 | MP0005266_abnormal_metabolism | 0.54823214 |
| 148 | MP0002136_abnormal_kidney_physiology | 0.54130382 |
| 149 | MP0001440_abnormal_grooming_behavior | 0.53557377 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.51766700 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.51090278 |
| 152 | MP0004858_abnormal_nervous_system | 0.51046510 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.50126106 |
| 154 | MP0008872_abnormal_physiological_respon | 0.49835474 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.49036222 |
| 156 | MP0004859_abnormal_synaptic_plasticity | 0.48429899 |
| 157 | MP0008873_increased_physiological_sensi | 0.47874794 |
| 158 | MP0005670_abnormal_white_adipose | 0.47187595 |
| 159 | MP0002332_abnormal_exercise_endurance | 0.45031084 |
| 160 | MP0002970_abnormal_white_adipose | 0.44645774 |
| 161 | MP0003631_nervous_system_phenotype | 0.44131087 |
| 162 | MP0005166_decreased_susceptibility_to | 0.43942954 |
| 163 | MP0005248_abnormal_Harderian_gland | 0.43901133 |
| 164 | MP0005448_abnormal_energy_balance | 0.43759310 |
| 165 | MP0006035_abnormal_mitochondrial_morpho | 0.43531016 |
| 166 | MP0008961_abnormal_basal_metabolism | 0.43481201 |
| 167 | MP0002229_neurodegeneration | 0.42883750 |
| 168 | MP0006036_abnormal_mitochondrial_physio | 0.42625152 |
| 169 | MP0005167_abnormal_blood-brain_barrier | 0.41627050 |
| 170 | MP0003045_fibrosis | 0.41612430 |
| 171 | MP0002064_seizures | 0.41481965 |
| 172 | MP0009115_abnormal_fat_cell | 0.40591797 |
| 173 | MP0003632_abnormal_nervous_system | 0.38991451 |
| 174 | MP0001502_abnormal_circadian_rhythm | 0.38937211 |
| 175 | MP0000230_abnormal_systemic_arterial | 0.38883084 |
| 176 | MP0005408_hypopigmentation | 0.36759965 |
| 177 | MP0005551_abnormal_eye_electrophysiolog | 0.36581666 |
| 178 | MP0003953_abnormal_hormone_level | 0.36049210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.00019435 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.46696504 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.36496753 |
| 4 | Xanthomatosis (HP:0000991) | 5.62659883 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61070447 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.45449519 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.16003994 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.07931483 |
| 9 | Complement deficiency (HP:0004431) | 4.66310076 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 4.44412244 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 4.33889115 |
| 12 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.25857907 |
| 13 | Joint hemorrhage (HP:0005261) | 4.21700525 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11808400 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.88683447 |
| 16 | Osteolytic defects of the hand bones (HP:0009699) | 3.76426876 |
| 17 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.76426876 |
| 18 | Epidermoid cyst (HP:0200040) | 3.75567130 |
| 19 | Poikilocytosis (HP:0004447) | 3.75501661 |
| 20 | Hyperammonemia (HP:0001987) | 3.74849906 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.71377872 |
| 22 | Ketosis (HP:0001946) | 3.66308847 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66095769 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.63302317 |
| 25 | Peritonitis (HP:0002586) | 3.60724741 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.58714606 |
| 27 | Acanthocytosis (HP:0001927) | 3.51750771 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.49116029 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.48074843 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.46715428 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46715428 |
| 32 | Hyperglycinemia (HP:0002154) | 3.46057820 |
| 33 | Fat malabsorption (HP:0002630) | 3.40938015 |
| 34 | Hyperglycinuria (HP:0003108) | 3.40780819 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.39665954 |
| 36 | Aortic aneurysm (HP:0004942) | 3.30753478 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.30299423 |
| 38 | Arterial tortuosity (HP:0005116) | 3.29592653 |
| 39 | Microcytic anemia (HP:0001935) | 3.27682000 |
| 40 | Abnormality of complement system (HP:0005339) | 3.24398990 |
| 41 | Aortic dissection (HP:0002647) | 3.19686458 |
| 42 | Vascular tortuosity (HP:0004948) | 3.17862948 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.12407451 |
| 44 | Cholelithiasis (HP:0001081) | 3.12332213 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 3.09269640 |
| 46 | Abnormal gallbladder morphology (HP:0012437) | 3.05722241 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 3.04880220 |
| 48 | Premature rupture of membranes (HP:0001788) | 2.99006624 |
| 49 | Absent frontal sinuses (HP:0002688) | 2.93416299 |
| 50 | Conjunctival telangiectasia (HP:0000524) | 2.86922973 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.86742440 |
| 52 | Reticulocytosis (HP:0001923) | 2.82683427 |
| 53 | Thyroid carcinoma (HP:0002890) | 2.82561943 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.79352574 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.78454050 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.77456624 |
| 57 | Abnormal gallbladder physiology (HP:0012438) | 2.76084750 |
| 58 | Cholecystitis (HP:0001082) | 2.76084750 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.75571188 |
| 60 | Myocardial infarction (HP:0001658) | 2.72514741 |
| 61 | Overgrowth (HP:0001548) | 2.66638720 |
| 62 | Gout (HP:0001997) | 2.64951020 |
| 63 | Ketoacidosis (HP:0001993) | 2.64796258 |
| 64 | Mitral valve prolapse (HP:0001634) | 2.62372771 |
| 65 | Spontaneous abortion (HP:0005268) | 2.56682641 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.55625905 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.54981580 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53650960 |
| 69 | Vascular calcification (HP:0004934) | 2.50419705 |
| 70 | Back pain (HP:0003418) | 2.50260805 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.48839540 |
| 72 | Status epilepticus (HP:0002133) | 2.45515134 |
| 73 | Wormian bones (HP:0002645) | 2.45373874 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.44121802 |
| 75 | Glucose intolerance (HP:0000833) | 2.43856273 |
| 76 | Spondylolisthesis (HP:0003302) | 2.42066424 |
| 77 | Steatorrhea (HP:0002570) | 2.40816481 |
| 78 | Metabolic acidosis (HP:0001942) | 2.39789669 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 2.39266719 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37837511 |
| 81 | Syringomyelia (HP:0003396) | 2.37400264 |
| 82 | Spinal cord lesions (HP:0100561) | 2.37400264 |
| 83 | Amyloidosis (HP:0011034) | 2.35998689 |
| 84 | Skin nodule (HP:0200036) | 2.35696800 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34979097 |
| 86 | Mitral stenosis (HP:0001718) | 2.34804252 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.33229027 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.33220257 |
| 89 | Resting tremor (HP:0002322) | 2.30020474 |
| 90 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.29459362 |
| 91 | Heterotopia (HP:0002282) | 2.28348475 |
| 92 | Curly hair (HP:0002212) | 2.25614295 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 2.24589129 |
| 94 | Macroorchidism (HP:0000053) | 2.24275930 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.24047670 |
| 96 | Rickets (HP:0002748) | 2.21933926 |
| 97 | Acute myeloid leukemia (HP:0004808) | 2.20796900 |
| 98 | Menorrhagia (HP:0000132) | 2.19837044 |
| 99 | Hydroxyprolinuria (HP:0003080) | 2.18438521 |
| 100 | Abnormality of proline metabolism (HP:0010907) | 2.18438521 |
| 101 | Orthostatic hypotension (HP:0001278) | 2.17214821 |
| 102 | Spontaneous hematomas (HP:0007420) | 2.16193000 |
| 103 | Periodontitis (HP:0000704) | 2.16183418 |
| 104 | Enlarged kidneys (HP:0000105) | 2.14431825 |
| 105 | Submucous cleft hard palate (HP:0000176) | 2.14418115 |
| 106 | Hyperkalemia (HP:0002153) | 2.11738928 |
| 107 | Malnutrition (HP:0004395) | 2.09833966 |
| 108 | Neonatal onset (HP:0003623) | 2.08757083 |
| 109 | Soft skin (HP:0000977) | 2.07959300 |
| 110 | Gingival bleeding (HP:0000225) | 2.07037545 |
| 111 | Esophageal varix (HP:0002040) | 2.06791093 |
| 112 | Spastic diplegia (HP:0001264) | 2.06670606 |
| 113 | Narrow palate (HP:0000189) | 2.06071247 |
| 114 | Abnormality of serum amino acid levels (HP:0003112) | 2.01215437 |
| 115 | Irritability (HP:0000737) | 2.01045940 |
| 116 | Neurofibrillary tangles (HP:0002185) | 2.00460605 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 1.99811315 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 1.99740841 |
| 119 | Confusion (HP:0001289) | 1.97909832 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.95594279 |
| 121 | Polycythemia (HP:0001901) | 1.94988927 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92927479 |
| 123 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.92632813 |
| 124 | Alkalosis (HP:0001948) | 1.92447313 |
| 125 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.91337103 |
| 126 | Turricephaly (HP:0000262) | 1.90476280 |
| 127 | Abnormal glucose tolerance (HP:0001952) | 1.89350320 |
| 128 | Vertebral arch anomaly (HP:0008438) | 1.88980792 |
| 129 | Hematochezia (HP:0002573) | 1.86493905 |
| 130 | Thoracolumbar scoliosis (HP:0002944) | 1.84740865 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.84533064 |
| 132 | Bladder carcinoma (HP:0002862) | 1.83455009 |
| 133 | Bladder neoplasm (HP:0009725) | 1.83455009 |
| 134 | Increased mean platelet volume (HP:0011877) | 1.82346930 |
| 135 | Metaphyseal dysplasia (HP:0100255) | 1.80879405 |
| 136 | Pseudobulbar signs (HP:0002200) | 1.80672606 |
| 137 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80134948 |
| 138 | Cystic hygroma (HP:0000476) | 1.79693490 |
| 139 | Asymmetry of the thorax (HP:0001555) | 1.78818107 |
| 140 | Dicarboxylic aciduria (HP:0003215) | 1.77261923 |
| 141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77261923 |
| 142 | T lymphocytopenia (HP:0005403) | 1.76865829 |
| 143 | Pulmonic stenosis (HP:0001642) | 1.76810871 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.76248901 |
| 145 | Menstrual irregularities (HP:0000858) | 1.75049585 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.74373025 |
| 147 | Truncal obesity (HP:0001956) | 1.73663609 |
| 148 | Difficulty running (HP:0009046) | 1.73329044 |
| 149 | Hypoglycemic seizures (HP:0002173) | 1.71754294 |
| 150 | Joint laxity (HP:0001388) | 1.71075498 |
| 151 | Scanning speech (HP:0002168) | 1.70809530 |
| 152 | Aneurysm (HP:0002617) | 1.70661624 |
| 153 | Short nail (HP:0001799) | 1.70057551 |
| 154 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.69630535 |
| 155 | Postural instability (HP:0002172) | 1.69476729 |
| 156 | Volvulus (HP:0002580) | 1.68302993 |
| 157 | Vomiting (HP:0002013) | 1.66904804 |
| 158 | Bile duct proliferation (HP:0001408) | 1.66511746 |
| 159 | Abnormal biliary tract physiology (HP:0012439) | 1.66511746 |
| 160 | Biliary tract neoplasm (HP:0100574) | 1.66503397 |
| 161 | Global brain atrophy (HP:0002283) | 1.65902788 |
| 162 | Ankyloglossia (HP:0010296) | 1.65563624 |
| 163 | Autoamputation (HP:0001218) | 1.65374699 |
| 164 | Hypochromic anemia (HP:0001931) | 1.65192276 |
| 165 | Thrombophlebitis (HP:0004418) | 1.65007780 |
| 166 | Intention tremor (HP:0002080) | 1.64972358 |
| 167 | Tetraparesis (HP:0002273) | 1.64960280 |
| 168 | Deep philtrum (HP:0002002) | 1.64473368 |
| 169 | Flat acetabular roof (HP:0003180) | 1.64283374 |
| 170 | Fair hair (HP:0002286) | 1.64181588 |
| 171 | Termporal pattern (HP:0011008) | 1.63254844 |
| 172 | Insidious onset (HP:0003587) | 1.63254844 |
| 173 | Subaortic stenosis (HP:0001682) | 1.60337741 |
| 174 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.60337741 |
| 175 | Stroke (HP:0001297) | 1.60230225 |
| 176 | Tetraplegia (HP:0002445) | 1.60227802 |
| 177 | Ankle contracture (HP:0006466) | 1.60160220 |
| 178 | Abnormality of T cell number (HP:0011839) | 1.60101093 |
| 179 | Abnormality of the frontal sinuses (HP:0002687) | 1.59950808 |
| 180 | Glomerulonephritis (HP:0000099) | 1.59545539 |
| 181 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.59047074 |
| 182 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.58441195 |
| 183 | Thickened calvaria (HP:0002684) | 1.58115089 |
| 184 | Long eyelashes (HP:0000527) | 1.58021577 |
| 185 | Large earlobe (HP:0009748) | 1.57584603 |
| 186 | Abnormal foot bone ossification (HP:0010675) | 1.56579119 |
| 187 | Cubitus valgus (HP:0002967) | 1.56415460 |
| 188 | Cerebral aneurysm (HP:0004944) | 1.56114983 |
| 189 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.54997288 |
| 190 | Gastrointestinal carcinoma (HP:0002672) | 1.54997288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.77971392 |
| 2 | SIK1 | 3.21042836 |
| 3 | AKT3 | 2.82587539 |
| 4 | BCKDK | 2.70360572 |
| 5 | FGFR4 | 2.43319352 |
| 6 | TRIB3 | 2.31311040 |
| 7 | EPHB1 | 2.24152239 |
| 8 | BRD4 | 2.23397018 |
| 9 | MAP2K4 | 2.11678121 |
| 10 | NEK9 | 2.11047207 |
| 11 | STK4 | 1.87947917 |
| 12 | CDK12 | 1.82464546 |
| 13 | ERN1 | 1.82245462 |
| 14 | ICK | 1.79111795 |
| 15 | PKN2 | 1.76289623 |
| 16 | GRK6 | 1.66542625 |
| 17 | RIPK1 | 1.63981711 |
| 18 | STK3 | 1.63528998 |
| 19 | STK38L | 1.58075559 |
| 20 | TAOK3 | 1.57988961 |
| 21 | EEF2K | 1.56210256 |
| 22 | MAPK15 | 1.55119261 |
| 23 | FGFR2 | 1.47400969 |
| 24 | PLK2 | 1.46889800 |
| 25 | LATS1 | 1.42884417 |
| 26 | DYRK3 | 1.41275629 |
| 27 | MAPK11 | 1.40487162 |
| 28 | FGFR3 | 1.39814898 |
| 29 | DAPK2 | 1.39353507 |
| 30 | MAP3K7 | 1.38758730 |
| 31 | PTK6 | 1.38622233 |
| 32 | ACVR1B | 1.32231621 |
| 33 | YES1 | 1.28719184 |
| 34 | STK24 | 1.28407678 |
| 35 | NTRK1 | 1.28183351 |
| 36 | DMPK | 1.25573326 |
| 37 | STK38 | 1.24934100 |
| 38 | EPHA4 | 1.24636629 |
| 39 | ERBB4 | 1.23774676 |
| 40 | WNK4 | 1.23596688 |
| 41 | MAP3K3 | 1.22774891 |
| 42 | SGK3 | 1.22330216 |
| 43 | PDGFRB | 1.21958631 |
| 44 | FRK | 1.16900715 |
| 45 | BMX | 1.16729447 |
| 46 | NLK | 1.15643745 |
| 47 | JAK2 | 1.15395230 |
| 48 | STK39 | 1.14636011 |
| 49 | PIM1 | 1.11300639 |
| 50 | CAMK1G | 1.10611120 |
| 51 | KSR2 | 1.08876258 |
| 52 | CSK | 1.07675174 |
| 53 | PRKCH | 1.07573648 |
| 54 | MAP3K10 | 1.03001451 |
| 55 | SGK223 | 1.01647053 |
| 56 | SGK494 | 1.01647053 |
| 57 | MELK | 1.01218402 |
| 58 | OXSR1 | 0.99880768 |
| 59 | MYLK | 0.99705909 |
| 60 | PDPK1 | 0.99430621 |
| 61 | TYRO3 | 0.97270833 |
| 62 | PRKAA2 | 0.95327249 |
| 63 | PRKCZ | 0.94325800 |
| 64 | MAP3K9 | 0.93503180 |
| 65 | RET | 0.92334671 |
| 66 | CAMKK1 | 0.91990548 |
| 67 | HIPK2 | 0.91049307 |
| 68 | TTN | 0.90672450 |
| 69 | TNIK | 0.89601712 |
| 70 | TYK2 | 0.89224481 |
| 71 | CDK6 | 0.88551262 |
| 72 | KSR1 | 0.88280347 |
| 73 | MAPK12 | 0.88271594 |
| 74 | PTK2 | 0.87702921 |
| 75 | ERBB2 | 0.87458839 |
| 76 | SGK2 | 0.86856704 |
| 77 | SCYL2 | 0.85653074 |
| 78 | PDK1 | 0.84658705 |
| 79 | ERBB3 | 0.83918419 |
| 80 | INSRR | 0.82894859 |
| 81 | PAK3 | 0.82642978 |
| 82 | WNK1 | 0.81690599 |
| 83 | RAF1 | 0.81556200 |
| 84 | TBK1 | 0.80895338 |
| 85 | MAP3K6 | 0.80573189 |
| 86 | MET | 0.80271779 |
| 87 | GRK5 | 0.79761921 |
| 88 | PBK | 0.79272943 |
| 89 | PTK2B | 0.78291803 |
| 90 | MAP3K2 | 0.77926799 |
| 91 | PKN1 | 0.77657436 |
| 92 | PAK6 | 0.76719626 |
| 93 | FES | 0.75911318 |
| 94 | GSK3A | 0.75087156 |
| 95 | TRPM7 | 0.75024795 |
| 96 | BLK | 0.74746831 |
| 97 | PINK1 | 0.74571721 |
| 98 | BRSK2 | 0.74359168 |
| 99 | MAP2K3 | 0.74072708 |
| 100 | FGR | 0.71663087 |
| 101 | NUAK1 | 0.71000748 |
| 102 | PRKD2 | 0.70517267 |
| 103 | PRKAA1 | 0.69524540 |
| 104 | CAMK1D | 0.69090143 |
| 105 | MAPK7 | 0.67758590 |
| 106 | MAP3K13 | 0.67666084 |
| 107 | PRKCQ | 0.67001020 |
| 108 | PRPF4B | 0.65989573 |
| 109 | JAK1 | 0.65464143 |
| 110 | TAOK2 | 0.62636302 |
| 111 | PRKACG | 0.62579559 |
| 112 | MAP3K5 | 0.61773179 |
| 113 | JAK3 | 0.61476996 |
| 114 | MAP3K1 | 0.61128685 |
| 115 | MST1R | 0.59740722 |
| 116 | EGFR | 0.59739734 |
| 117 | TAOK1 | 0.59257738 |
| 118 | SIK2 | 0.58958663 |
| 119 | TGFBR2 | 0.58942432 |
| 120 | PIK3CG | 0.58713767 |
| 121 | EIF2AK3 | 0.57680453 |
| 122 | PDGFRA | 0.57555572 |
| 123 | ABL2 | 0.57437162 |
| 124 | BMPR2 | 0.56563819 |
| 125 | DYRK1A | 0.55769513 |
| 126 | MAP2K1 | 0.54367763 |
| 127 | OBSCN | 0.53683198 |
| 128 | STK11 | 0.53288597 |
| 129 | DYRK1B | 0.51811382 |
| 130 | MAP3K4 | 0.51595701 |
| 131 | PLK3 | 0.51568905 |
| 132 | MAPK4 | 0.51085132 |
| 133 | MAP3K14 | 0.51052772 |
| 134 | MARK2 | 0.50555287 |
| 135 | IKBKE | 0.50459975 |
| 136 | DDR2 | 0.49572867 |
| 137 | MAP2K6 | 0.49159654 |
| 138 | NTRK3 | 0.48886326 |
| 139 | CAMK4 | 0.48293968 |
| 140 | MTOR | 0.48070995 |
| 141 | TEC | 0.47753204 |
| 142 | FLT3 | 0.47044838 |
| 143 | SGK1 | 0.46960592 |
| 144 | RPS6KA3 | 0.45351695 |
| 145 | CSNK1G2 | 0.44976517 |
| 146 | PNCK | 0.43812108 |
| 147 | SYK | 0.43727322 |
| 148 | MST4 | 0.39938501 |
| 149 | FGFR1 | 0.37990322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.41302320 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06499559 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11754656 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04745606 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94633942 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57623480 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48023840 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47070294 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29949817 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24949900 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24380603 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21411641 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16035299 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11455662 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05505144 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.01068075 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89908657 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.88695632 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88059548 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87228130 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.85167936 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.84687663 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.78344321 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76245366 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75553181 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74294353 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.73186283 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68218071 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67961651 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66846572 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.66808194 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60565244 |
| 33 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.58060951 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.55504928 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.53864471 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.53722851 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.53249237 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46625464 |
| 39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.44040834 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44012220 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43626341 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.42858323 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41874190 |
| 44 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.38016419 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.37931583 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.37103546 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 1.35756449 |
| 48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34639359 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33472282 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.31136179 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 1.30318513 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.29466944 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28357394 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27319118 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25653032 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25071245 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24808929 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20253892 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18286892 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17527689 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15705537 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15290806 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14585054 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14173086 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13453040 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10398933 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09079889 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 1.08173187 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08121830 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07364448 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 1.06446896 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05925369 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05115868 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01933742 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01135494 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00046054 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99407136 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.97958612 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96769296 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94144789 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.93357291 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.93263975 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93021482 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92864509 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.90807374 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88061221 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87973971 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86816321 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.86451291 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86156449 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.85543402 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83822938 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83310266 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83212529 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82363185 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.82184099 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81452858 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81305632 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80933846 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.80543280 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79391165 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79189973 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79134875 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78412882 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77907004 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75668152 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74322304 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71262627 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70147919 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69518112 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69270276 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68881307 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67080581 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66643687 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66478251 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66095014 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65203353 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64337604 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.63333313 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62253615 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61007655 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60048098 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.59125797 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58079124 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57847704 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57428184 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56826736 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56751350 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56425560 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55312953 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54441081 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54250169 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53650141 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53247939 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52765726 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51369738 |
| 137 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50823730 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50245128 |
| 139 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48643227 |
| 140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48463954 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47310546 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.41929455 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41769459 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.40803582 |
| 145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38867136 |
| 146 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38378203 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34638417 |
| 148 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32267996 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22867073 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20208509 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20039491 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18230437 |
| 153 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17236252 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16979222 |
| 155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15056295 |
| 156 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13069363 |
| 157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12785523 |
| 158 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12717387 |
| 159 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10738878 |
| 160 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09409386 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09284161 |
| 162 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06117929 |
| 163 | Salivary secretion_Homo sapiens_hsa04970 | 0.02168317 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02125976 |
| 165 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01370374 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01249123 |
| 167 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.01046214 |
| 168 | Mineral absorption_Homo sapiens_hsa04978 | 0.00894869 |
| 169 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.00414002 |
| 170 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0483317 |
| 171 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0444248 |
| 172 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0436717 |
| 173 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0421885 |
| 174 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0286947 |
| 175 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0280418 |
| 176 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0253359 |
| 177 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0217187 |
| 178 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0200615 |
| 179 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0176803 |

